Clinical Trial Update: Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -

View source ↗

Summary

A completed surveillance trial evaluating high-dose (>6 g daily) intravenous ampicillin/sulbactam (Unasyn-S) usage, with results posted for pneumonia, lung absc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Abscess
• Peritonitis
• Pneumonia

Drugs mentioned

• Unasyn-S (ampicillin-sulbactam)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia, Lung Abscess | Status: COMPLETED | Results posted: 2017-04-26